How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

120 results for

FOUR Score Coma Exam

by
...
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

61. Cataract Surgery Guidelines

2000;77:13-24. 2. Lundstrom M, Stenevi U, Thorburn W. Quality of life after first- and second-eye cataract surgery: five- year data collected by the Swedish National Cataract Register. J Cataract Refract Surg 2001;27:1553-9. 3. Javitt JC, Brenner MH, Curbow B, et al. Outcomes of cataract surgery. Improvement in visual acuity and subjective visual function after surgery in the first, second, and both eyes. Arch Ophthalmol 1993;111:686-91. 4. Castells X, Comas M, Alonso J, et al. In a randomized (...) to the adult eye) ? Potential for amblyopia ? Long life span after cataract removal These facts must be taken into account and their impact understood by any surgeon undertaking cataract surgery in children. 6.7 Evaluation History Should include history of pregnancy and family history III IV ARCHIVED see NICE cataracty surgery guidelines 201728 Examination Should include examination of the child and a dilated exam of the lenses of both parents Investigations Neonates with bilateral cataracts and no family

2010 Royal College of Ophthalmologists

62. Addyi - Flibanserin

flibanserin was co-administered with both ethanol concentrations. The hypotensive effect of the interaction can be profound – in four male subjects (17%, 4/23) receiving low dose ethanol, the magnitude of the systolic blood pressure reductions ranged from about 28 to 54 mmHg and the magnitude of the diastolic blood pressure reductions ranged from about 24 to 46 mmHg. All four subjects received medical intervention. One of these subjects also experienced syncope; his blood pressure at the time of the event (...) that potentially contribute to the metabolism of flibanserin.” CDTL comment: Four combined cases of syncope and severe hypotension were observed in Studies 511.111 and SPR-12-01. The magnitude of increase in flibanserin exposure when used in combination with strong or moderate CYP3A4 inhibitors could lead to many such adverse events if flibanserin is made available. Even if the use of strong or moderate CYP3A4 is contraindicated, existing automatic screening systems in pharmacies may not eliminate concomitant

2015 FDA - Drug Approval Package

63. Management of Stroke Rehabilitation

to care • Utilization of healthcare Version 2.0 VA/DoD Clinical Practice Guideline for the October, 2010 Management of Stroke Rehabilitation Introduction Page - 4 Effective rehabilitation improves functional outcome. An indicator for improvement is the positive change in the Functional Independence Measures (FIM TM ) (UDS MR for1997, 1998) score over a period of time in the post- acute care period. Within the Veterans Health Administration (VHA) this measure is captured in the Functional Status (...) management of risk factors and co-morbidities is essential to ensure survival. OUTCOME MEASURES 1. Effective rehabilitation improves functional outcome. An indicator for improvement is the positive change in the Functional Independence Measures (FIM TM ) score over a period of time in the post-acute care period. Within the Veterans Health Administration (VHA) this measure is captured in the Functional Status and Outcomes Database for rehabilitation. All stroke patients should be entered into the database

2010 VA/DoD Clinical Practice Guidelines

64. Thoracic Aortic Disease: Guidelines For the Diagnosis and Management of Patients With

resonance imaging (MR), or in some cases, echocardiographic exam- ination is the only method to detect thoracic aortic diseases and determine risk for future complications (see Section 4). • Radiologic imaging technologies have improved in terms of accuracy of detection of thoracic aortic disease. How- ever, as the use of these technologies has increased, so also has the potential risk associated with repeated radiation exposure, as well as contrast medium–related toxicity. Whether these technologies

2010 American College of Cardiology

65. Blunt Cerebrovascular Injury

with any neurologic abnormality that is unexplained by a diagnosed injury should be evaluated for BCVI. 2. Blunt trauma patients presenting with epistaxis from a suspected arterial source after trauma should be evaluated for BCVI. Level III: 1. Asymptomatic patients with significant blunt head trauma as defined below are at significantly increased risk for BCVI and screening should be considered. Risk factors are as follows: * Glasgow Coma Scale score ≤8; * Petrous bone fracture; * Diffuse axonal (...) factors for blunt carotid arterial injury (BCAI). These were (1) Glasgow Coma Scale score <6; (2) petrous fracture; (3) diffuse axonal injury; and (4) LeFort II or III fracture. Patients who had any of the above risk factors had a risk of 41% for BCAI. This risk increased to 93% in the presence of all 4 factors. The only risk factor for blunt vertebral artery injury (BVAI) was presence of cervical spine fracture. However, 20% of patients diagnosed with BCVI selected for screening by the criteria

2010 Eastern Association for the Surgery of Trauma

66. CPG on the Diagnosis, Treatment and Prevention of Tuberculosis

, Preventative Medicine and Public Health Physician, It has been 5 years since the publication of this Clinical Practice Guideline and it is subject to updating. CLINICAL PRACTICE GUIDELINE IN THE SNHS 12 Hospital General Universitario de Elche, Alicante Arturo Noguerado Asensio, Internal Medicine Physician, Hospital de Cantoblanco-La Paz, Madrid David Rigau Comas, Specialist Physician, Clinical Pharmacology, Iberoamerican Cochrane Centre; Hospital de la Santa Creu i Sant Pau, Barcelona Joan Roca Martínez (...) , Documentalist, Iberoamerican Cochrane Centre; Hospital de la Santa Creu i Sant Pau,Barcelona Rafael Vidal Pla, Pulmonologist, Hospital Vall d’Hebron, Barcelona Coordination David Rigau Comas, Rigau Comas, Specialist Physician, Clinical Pharmacology Iberoamerican Cochrane Centre; Hospital de la Santa Creu i Sant Pau, Barcelona Pablo Alonso Coello, Family and Community Medicine Physician Iberoamerican Cochrane Centre; Hospital de la Santa Creu i Sant Pau, Barcelona External Review External Review José Antonio

2010 GuiaSalud

67. CPG on the comprehensive care of people with Alzheimer's Disease and other Dementias

(Barcelona) M.ª Pilar Cañabate González, social worker, Fundació ACE, Institut Català de Neurociències Aplicades (Barcelona) Montserrat Coma Solé, general practitioner, Les Planes Primary Health Centre, Sant Joan Despí (Barcelona) Josep Lluís Conde Sala, psychologist, University of Barcelona Maria-Dolors Estrada Sabadell, public health and preventivist physician, Agència d’Informació, Avaluació i Qualitat en Salut (AIAQS) (Barcelona) It has been 5 years since the publication of this Clinical Practice

2010 GuiaSalud

68. Assessment and Treatment of Individuals with History of TBI and PTSD

- traumatic amnesia lasting >24 hr up to permanently, or Glasgow Coma score as low as 3 Focal neurologic signs Usually none or transient Frequently present Neuroimaging with CT or MRI Usually negative Diagnostic Natural History Full recovery is usual; there is lack of consensus on the natural history of concussion and post-concussive symptoms Natural history and recovery are directly related to the severity of the injury and functional neuroanatomy Case definitions and specificity of injury sequelae Case (...) will be disseminated broadly throughout V A and will: inform V A clinical policy, develop clinical practice guidelines, set directions for future research to address gaps in knowledge, identify the evidence to support V A performance measures, and rationalize drug formulary decisions. HSR&D provides funding for four ESP Centers. Each Center has an active and publicly acknowledged V A affiliation and also serves as an Evidence Based Practice Center (EPC) supported by the Agency for Healthcare Research and Quality

2009 Veterans Affairs Evidence-based Synthesis Program Reports

69. Nasopharyngeal Cancer, Childhood

with nasopharyngeal carcinoma present with advanced disease (stage III/IV or T3/T4).[ , ] Population-based studies have reported that patients younger than 20 years had a higher incidence of advanced-stage disease than did adult patients.[ , ] However, less than 10% of children and adolescents with nasopharyngeal carcinoma presented with distant metastases at diagnosis.[ - ] Prognosis The overall survival of children and adolescents with nasopharyngeal carcinoma has improved over the last four decades; with state (...) cytokeratin expression.[ ] Sixty-six samples of olfactory neuroblastoma and tumor samples from other cancers, including alveolar rhabdomyosarcoma and sinonasal adenocarcinoma, were obtained from nine medical centers and analyzed by genome-wide DNA methylation profiling, copy number analysis, immunohistochemistry, and next-generation panel sequencing. Unsupervised hierarchal clustering analysis of DNA methylation data identified the following four distinct clusters:[ ] The largest cluster, which comprised

2012 PDQ - NCI's Comprehensive Cancer Database

70. Multiple Endocrine Neoplasia, Childhood

with nasopharyngeal carcinoma present with advanced disease (stage III/IV or T3/T4).[ , ] Population-based studies have reported that patients younger than 20 years had a higher incidence of advanced-stage disease than did adult patients.[ , ] However, less than 10% of children and adolescents with nasopharyngeal carcinoma presented with distant metastases at diagnosis.[ - ] Prognosis The overall survival of children and adolescents with nasopharyngeal carcinoma has improved over the last four decades; with state (...) cytokeratin expression.[ ] Sixty-six samples of olfactory neuroblastoma and tumor samples from other cancers, including alveolar rhabdomyosarcoma and sinonasal adenocarcinoma, were obtained from nine medical centers and analyzed by genome-wide DNA methylation profiling, copy number analysis, immunohistochemistry, and next-generation panel sequencing. Unsupervised hierarchal clustering analysis of DNA methylation data identified the following four distinct clusters:[ ] The largest cluster, which comprised

2012 PDQ - NCI's Comprehensive Cancer Database

71. Mesothelioma, Childhood

with nasopharyngeal carcinoma present with advanced disease (stage III/IV or T3/T4).[ , ] Population-based studies have reported that patients younger than 20 years had a higher incidence of advanced-stage disease than did adult patients.[ , ] However, less than 10% of children and adolescents with nasopharyngeal carcinoma presented with distant metastases at diagnosis.[ - ] Prognosis The overall survival of children and adolescents with nasopharyngeal carcinoma has improved over the last four decades; with state (...) cytokeratin expression.[ ] Sixty-six samples of olfactory neuroblastoma and tumor samples from other cancers, including alveolar rhabdomyosarcoma and sinonasal adenocarcinoma, were obtained from nine medical centers and analyzed by genome-wide DNA methylation profiling, copy number analysis, immunohistochemistry, and next-generation panel sequencing. Unsupervised hierarchal clustering analysis of DNA methylation data identified the following four distinct clusters:[ ] The largest cluster, which comprised

2012 PDQ - NCI's Comprehensive Cancer Database

72. Midline Tract Carcinoma, Childhood

with nasopharyngeal carcinoma present with advanced disease (stage III/IV or T3/T4).[ , ] Population-based studies have reported that patients younger than 20 years had a higher incidence of advanced-stage disease than did adult patients.[ , ] However, less than 10% of children and adolescents with nasopharyngeal carcinoma presented with distant metastases at diagnosis.[ - ] Prognosis The overall survival of children and adolescents with nasopharyngeal carcinoma has improved over the last four decades; with state (...) cytokeratin expression.[ ] Sixty-six samples of olfactory neuroblastoma and tumor samples from other cancers, including alveolar rhabdomyosarcoma and sinonasal adenocarcinoma, were obtained from nine medical centers and analyzed by genome-wide DNA methylation profiling, copy number analysis, immunohistochemistry, and next-generation panel sequencing. Unsupervised hierarchal clustering analysis of DNA methylation data identified the following four distinct clusters:[ ] The largest cluster, which comprised

2012 PDQ - NCI's Comprehensive Cancer Database

73. Papillomatosis, Childhood

with nasopharyngeal carcinoma present with advanced disease (stage III/IV or T3/T4).[ , ] Population-based studies have reported that patients younger than 20 years had a higher incidence of advanced-stage disease than did adult patients.[ , ] However, less than 10% of children and adolescents with nasopharyngeal carcinoma presented with distant metastases at diagnosis.[ - ] Prognosis The overall survival of children and adolescents with nasopharyngeal carcinoma has improved over the last four decades; with state (...) cytokeratin expression.[ ] Sixty-six samples of olfactory neuroblastoma and tumor samples from other cancers, including alveolar rhabdomyosarcoma and sinonasal adenocarcinoma, were obtained from nine medical centers and analyzed by genome-wide DNA methylation profiling, copy number analysis, immunohistochemistry, and next-generation panel sequencing. Unsupervised hierarchal clustering analysis of DNA methylation data identified the following four distinct clusters:[ ] The largest cluster, which comprised

2012 PDQ - NCI's Comprehensive Cancer Database

74. Head and Neck Cancer, Childhood

with nasopharyngeal carcinoma present with advanced disease (stage III/IV or T3/T4).[ , ] Population-based studies have reported that patients younger than 20 years had a higher incidence of advanced-stage disease than did adult patients.[ , ] However, less than 10% of children and adolescents with nasopharyngeal carcinoma presented with distant metastases at diagnosis.[ - ] Prognosis The overall survival of children and adolescents with nasopharyngeal carcinoma has improved over the last four decades; with state (...) cytokeratin expression.[ ] Sixty-six samples of olfactory neuroblastoma and tumor samples from other cancers, including alveolar rhabdomyosarcoma and sinonasal adenocarcinoma, were obtained from nine medical centers and analyzed by genome-wide DNA methylation profiling, copy number analysis, immunohistochemistry, and next-generation panel sequencing. Unsupervised hierarchal clustering analysis of DNA methylation data identified the following four distinct clusters:[ ] The largest cluster, which comprised

2012 PDQ - NCI's Comprehensive Cancer Database

75. Gastrointestinal Stromal Tumors, Childhood

with nasopharyngeal carcinoma present with advanced disease (stage III/IV or T3/T4).[ , ] Population-based studies have reported that patients younger than 20 years had a higher incidence of advanced-stage disease than did adult patients.[ , ] However, less than 10% of children and adolescents with nasopharyngeal carcinoma presented with distant metastases at diagnosis.[ - ] Prognosis The overall survival of children and adolescents with nasopharyngeal carcinoma has improved over the last four decades; with state (...) cytokeratin expression.[ ] Sixty-six samples of olfactory neuroblastoma and tumor samples from other cancers, including alveolar rhabdomyosarcoma and sinonasal adenocarcinoma, were obtained from nine medical centers and analyzed by genome-wide DNA methylation profiling, copy number analysis, immunohistochemistry, and next-generation panel sequencing. Unsupervised hierarchal clustering analysis of DNA methylation data identified the following four distinct clusters:[ ] The largest cluster, which comprised

2012 PDQ - NCI's Comprehensive Cancer Database

76. Esthesioneuroblastoma, Childhood

with nasopharyngeal carcinoma present with advanced disease (stage III/IV or T3/T4).[ , ] Population-based studies have reported that patients younger than 20 years had a higher incidence of advanced-stage disease than did adult patients.[ , ] However, less than 10% of children and adolescents with nasopharyngeal carcinoma presented with distant metastases at diagnosis.[ - ] Prognosis The overall survival of children and adolescents with nasopharyngeal carcinoma has improved over the last four decades; with state (...) cytokeratin expression.[ ] Sixty-six samples of olfactory neuroblastoma and tumor samples from other cancers, including alveolar rhabdomyosarcoma and sinonasal adenocarcinoma, were obtained from nine medical centers and analyzed by genome-wide DNA methylation profiling, copy number analysis, immunohistochemistry, and next-generation panel sequencing. Unsupervised hierarchal clustering analysis of DNA methylation data identified the following four distinct clusters:[ ] The largest cluster, which comprised

2012 PDQ - NCI's Comprehensive Cancer Database

77. Stomach (Gastric) Cancer, Childhood

with nasopharyngeal carcinoma present with advanced disease (stage III/IV or T3/T4).[ , ] Population-based studies have reported that patients younger than 20 years had a higher incidence of advanced-stage disease than did adult patients.[ , ] However, less than 10% of children and adolescents with nasopharyngeal carcinoma presented with distant metastases at diagnosis.[ - ] Prognosis The overall survival of children and adolescents with nasopharyngeal carcinoma has improved over the last four decades; with state (...) cytokeratin expression.[ ] Sixty-six samples of olfactory neuroblastoma and tumor samples from other cancers, including alveolar rhabdomyosarcoma and sinonasal adenocarcinoma, were obtained from nine medical centers and analyzed by genome-wide DNA methylation profiling, copy number analysis, immunohistochemistry, and next-generation panel sequencing. Unsupervised hierarchal clustering analysis of DNA methylation data identified the following four distinct clusters:[ ] The largest cluster, which comprised

2012 PDQ - NCI's Comprehensive Cancer Database

78. Colorectal Cancer, Childhood

with nasopharyngeal carcinoma present with advanced disease (stage III/IV or T3/T4).[ , ] Population-based studies have reported that patients younger than 20 years had a higher incidence of advanced-stage disease than did adult patients.[ , ] However, less than 10% of children and adolescents with nasopharyngeal carcinoma presented with distant metastases at diagnosis.[ - ] Prognosis The overall survival of children and adolescents with nasopharyngeal carcinoma has improved over the last four decades; with state (...) cytokeratin expression.[ ] Sixty-six samples of olfactory neuroblastoma and tumor samples from other cancers, including alveolar rhabdomyosarcoma and sinonasal adenocarcinoma, were obtained from nine medical centers and analyzed by genome-wide DNA methylation profiling, copy number analysis, immunohistochemistry, and next-generation panel sequencing. Unsupervised hierarchal clustering analysis of DNA methylation data identified the following four distinct clusters:[ ] The largest cluster, which comprised

2012 PDQ - NCI's Comprehensive Cancer Database

79. Esophageal Tumors, Childhood

with nasopharyngeal carcinoma present with advanced disease (stage III/IV or T3/T4).[ , ] Population-based studies have reported that patients younger than 20 years had a higher incidence of advanced-stage disease than did adult patients.[ , ] However, less than 10% of children and adolescents with nasopharyngeal carcinoma presented with distant metastases at diagnosis.[ - ] Prognosis The overall survival of children and adolescents with nasopharyngeal carcinoma has improved over the last four decades; with state (...) cytokeratin expression.[ ] Sixty-six samples of olfactory neuroblastoma and tumor samples from other cancers, including alveolar rhabdomyosarcoma and sinonasal adenocarcinoma, were obtained from nine medical centers and analyzed by genome-wide DNA methylation profiling, copy number analysis, immunohistochemistry, and next-generation panel sequencing. Unsupervised hierarchal clustering analysis of DNA methylation data identified the following four distinct clusters:[ ] The largest cluster, which comprised

2012 PDQ - NCI's Comprehensive Cancer Database

80. Chordoma, Childhood

with nasopharyngeal carcinoma present with advanced disease (stage III/IV or T3/T4).[ , ] Population-based studies have reported that patients younger than 20 years had a higher incidence of advanced-stage disease than did adult patients.[ , ] However, less than 10% of children and adolescents with nasopharyngeal carcinoma presented with distant metastases at diagnosis.[ - ] Prognosis The overall survival of children and adolescents with nasopharyngeal carcinoma has improved over the last four decades; with state (...) cytokeratin expression.[ ] Sixty-six samples of olfactory neuroblastoma and tumor samples from other cancers, including alveolar rhabdomyosarcoma and sinonasal adenocarcinoma, were obtained from nine medical centers and analyzed by genome-wide DNA methylation profiling, copy number analysis, immunohistochemistry, and next-generation panel sequencing. Unsupervised hierarchal clustering analysis of DNA methylation data identified the following four distinct clusters:[ ] The largest cluster, which comprised

2012 PDQ - NCI's Comprehensive Cancer Database

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>